Longboard Pharmaceuticals... (LBPH)
NASDAQ: LBPH
· Real-Time Price · USD
59.98
null (null%)
At close: Nov 29, 2024, 7:00 PM
Longboard Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -24.54M | -21.79M | -14.99M | -15.03M | -12.93M | -15M | -11.46M | -11.35M | -11.6M | -11.41M | -9.6M | -8.77M | -6.34M | -6.98M | -5.7M |
Depreciation & Amortization | 1K | 2K | 1K | 1K | 1K | 2K | 1K | 1K | 1K | 2K | 1K | 1K | n/a | n/a | n/a |
Stock-Based Compensation | 3.38M | 2.81M | 1.75M | 860K | 856K | 841K | 697K | 592K | 795K | 699K | 571K | 584K | 538K | 512K | 333K |
Other Working Capital | -1.46M | 1.46M | -135K | 2.9M | 567K | -584K | -1.31M | 509K | 859K | 2.94M | -1.47M | 2.36M | -447K | 1.89M | -2.65M |
Other Non-Cash Items | 3.37M | -1.67M | -141K | -397K | -203K | -371K | -1K | -162K | 114K | 4K | 145K | 20.58M | 144K | -2K | 58K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -20.56M | n/a | n/a | n/a |
Change in Working Capital | -2.8M | 2.89M | -92K | 3.54M | -1.01M | 1.07M | -2.34M | 1.24M | 833K | 2.19M | -1.15M | 2.5M | -471K | 1.32M | -2.38M |
Operating Cash Flow | -20.59M | -19.13M | -15.18M | -11.03M | -13.29M | -13.45M | -13.1M | -9.67M | -9.85M | -8.51M | -10.03M | -5.67M | -6.13M | -5.15M | -7.75M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3K | -13K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -61.95M | -98.89M | -255.12M | -18.66M | -18.65M | -13.84M | -20.57M | -6.77M | -16.56M | -13.01M | -21.28M | -3.44M | -9.25M | -28.01M | n/a |
Sales Maturities Of Investments | 95M | 78.2M | 24.2M | 17.1M | 30.4M | 21.8M | 26.65M | 8.91M | 17.44M | 14.2M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -20.69M | -230.92K | -1.56K | 11.75K | 7.96K | 6.08K | 2.15K | 882.00 | 1.19K | -21.28M | -3.44M | -13K | -28.01M | n/a |
Investing Cash Flow | 33.05M | -20.69M | -230.92M | -1.56M | 11.75M | 7.96M | 6.08M | 2.15M | 882K | 1.19M | -21.28M | -3.44M | -9.26M | -28.01M | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 560K | 21K | -14.95M | 183K | -14K | -125K | -1.64M | -444K | n/a | n/a | n/a | 8.32M | -2K | -1.6M | -6.72M |
Financial Cash Flow | 560K | 21K | 286.4M | 3.01M | 5.95M | -125K | 21.36M | -444K | n/a | n/a | n/a | n/a | -2K | 3.17M | 73.28M |
Net Cash Flow | 13.01M | -39.8M | 40.06M | -9.58M | 4.41M | -5.62M | 14.35M | -7.97M | -8.97M | -7.32M | -31.31M | -9.12M | -15.4M | -29.99M | 65.53M |
Free Cash Flow | -20.59M | -19.13M | -15.18M | -11.03M | -13.29M | -13.45M | -13.1M | -9.67M | -9.85M | -8.51M | -10.03M | -5.68M | -6.15M | -5.15M | -7.75M |